These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5143286)

  • 1. [Blood coagulation in patients with pulmonary tuberculosis in the course of treatment with tuberculostatic agents of the 1st and 2nd series].
    Chaban VM
    Vrach Delo; 1971 Nov; 11():75-8. PubMed ID: 5143286
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the blood coagulation in patients with pulmonary tuberculosis during treatment with preparations of the first order].
    Ivaniuta OM; Fomicheva NI; Chaban VM
    Vrach Delo; 1969 Aug; 8():38-9. PubMed ID: 5382482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of intravenous administration of 1st series preparations on blood coagulation in pulmonary and renal tuberculosis].
    Radkevich RA; Utkin VV; Gushanskiĭ AM
    Probl Tuberk; 1970; 48(7):31-5. PubMed ID: 5486078
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood bacteriostatic activity in pulmonary tuberculosis patients undergoing treatment with drugs of the 1st and 2d series].
    Alekseevskaia KP
    Probl Tuberk; 1972; 50(6):48-52. PubMed ID: 5051126
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravenous injection of tuberculostatic preparations in the treatment of patients with tuberculosis].
    Shebanov FV; Grigor'ev IuG
    Probl Tuberk; 1967; 45(9):14-21. PubMed ID: 5629172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of intravenous chemotherapy in the complex treatment of pulmonary tuberculosis].
    Zits VR
    Probl Tuberk; 1973; 51(10):85-6. PubMed ID: 4784047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation of plasma malonyl dialdehyde concentration in patients with pulmonary tuberculosis].
    Janiszewska-Drobińska B; Kowalski J; Błaszczyk J; Kedziora J; Kaczmarek P; Ciećwierz J
    Pol Merkur Lekarski; 2001 Oct; 11(64):310-3. PubMed ID: 11770308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Certain elements of peripheral blood and bone marrow in patients with pulmonary tuberculosis treated for the first time with antitubercular agents].
    Sikora-Rózyńska M
    Gruzlica; 1968 Jul; 36(7):631-9. PubMed ID: 5699437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Continuous regional and intravenous chemotherapy of pulmonary tuberculosis].
    Brandis IaS; Miroshnichenko SF
    Probl Tuberk; 1972; 50(11):25-9. PubMed ID: 4647613
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of serum neopterin level in the evaluation of activation and response to treatment in the patients with pulmonary tuberculosis].
    Güler M; Hüddam D; Unsal E; Ciftçi B; Bukan N; Erdoğan Y; Capan N
    Tuberk Toraks; 2006; 54(4):330-5. PubMed ID: 17203418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Exacerbations and relapses following an effective antibacterial treatment of patients with repeatedly detected destructive pulmonary tuberculosis].
    Ganushchak MM; Dubosarskiĭ AI
    Probl Tuberk; 1969; 47(3):34-8. PubMed ID: 5354632
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous chemotherapy of patients with cavernous forms of pulmonary tuberculosis].
    Shervchenko VV; Poluianova RP; Bukhteeva OP; Morozkina SN; Orinina TA
    Probl Tuberk; 1971; 49(12):23-6. PubMed ID: 5159682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous chemotherapy of patients with destructive forms of pulmonary tuberculosis].
    Mezenskaia AIa
    Probl Tuberk; 1971; 49(8):87-8. PubMed ID: 5152641
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis].
    Pletnev GV; Krasnov DV
    Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():143-51. PubMed ID: 4510911
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effectiveness of the complex use of tuberculostatic preparations in tuberculosis patients in sanitorium-climate treatment].
    Navrotskiĭ VV; Topchiev ShR
    Probl Tuberk; 1967; 45(1):43-6. PubMed ID: 5601298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.